500 Participants Needed

Endoscopic Tissue Apposition for Gastrointestinal Endoscopy

AL
Overseen ByAbigail Lowe
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Colorado, Denver
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new treatment technique called endoscopic tissue apposition, used to close openings or defects in the digestive tract. Researchers aim to determine if this method is both effective and safe for patients requiring procedures such as perforation closures or repairs after certain surgeries. Suitable candidates for this trial include those who have recently undergone an endoscopy for issues like fistulas or need repairs following bariatric surgery. Participants should not have bleeding problems or be involved in another study that might affect this one. As a Phase 3 trial, this treatment is in the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking medical advancement.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that endoscopic tissue apposition is safe for gastrointestinal endoscopy?

Research has shown that endoscopic tissue apposition is generally safe. For instance, a new clip with small anchor prongs was tested and proved safe for closing openings or tears inside the body. Another study found that special medical tools, such as forceps, were safe for closing large tissue openings. However, not all studies provide specific safety data for use in the digestive system. Still, other studies have reviewed the technique and suggest it is usually well-tolerated.

In summary, based on available research, the treatment is mostly considered safe. Reports indicate it is effective and carries a low risk of complications.12345

Why are researchers excited about this trial?

Endoscopic Tissue Apposition is unique because it uses a minimally invasive technique to close tissue without the need for traditional surgery. Most treatments for tissue repair involve surgical procedures, which can be more invasive and require longer recovery times. This method allows for quicker recovery and potentially fewer complications, as it reduces the physical impact on the body. Researchers are excited about this technique because it offers a safer and more efficient alternative to conventional surgical options.

What evidence suggests that endoscopic tissue apposition is effective for gastrointestinal endoscopy?

Studies have shown that endoscopic methods effectively close large openings in the digestive tract. One research study demonstrated that special devices successfully closed these openings. Another study found that a specific type of clip achieved success in 89.1% of cases, leading to health improvements in 85.2% of patients. Early experiences with these devices also showed success in about 89% of patients. These findings suggest that endoscopic methods offer a promising approach to improving digestive procedures.678910

Are You a Good Fit for This Trial?

Inclusion Criteria

Closure of perforations
Closure of full thickness defects created during endoscopic full thickness resection
Closure of defects after endoscopic submucosal dissection and endoscopic mucosal resection
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo endoscopic suturing and/or clip placement to assess efficacy and safety

Baseline to one year

Follow-up

Participants are monitored for safety and effectiveness after treatment

Up to one year

What Are the Treatments Tested in This Trial?

Interventions

  • Endoscopic Tissue Apposition

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Colorado, Denver

Lead Sponsor

Trials
1,842
Recruited
3,028,000+

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40640617/
RCT comparing the clinical efficacy and costs of two tissue ...In this RCT, both TTS approximation devices equally facilitated approximation/closure of large ERD. Approximation with the DAT clip was ...
Endoscopic suturing and clipping devices for defects in the ...OTSC was successfully deployed at a rate of 89.1 % (95%CI: 81.6%–93.8 %; I2 = 41.06 %) and clinical improvement was recorded in 85.2 % (95%CI: 71.9%–92.8 %, I2 ...
Official journal of the American College of GastroenterologyIn this study we compare the clinical efficacy and cost of 2 novel through the scope (TTS) tissue approximation devices in the management of large ERD.
Prospective Evaluation of the Efficacy and Safety of ...1.2 Aims: To prospectively evaluate the efficacy and safety of Endoscopic Tissue Apposition in the practice of gastrointestinal endoscopy.
Initial multicenter experience using a novel endoscopic ...Technical success of the intended use of the device was achieved in 83 patients (89.2%). Closure was partially successful in 8 patients (8.6%), ...
A new through-the-scope clip with anchor prongs is safe ...A novel TTSC with anchor prongs showed success in a range of defect closures, an acceptable safety profile, and low incidence of technical difficulties.
Efficacy and safety of a multi-degree-of-freedom ...The MDOF articulating forceps seem to be an effective and safe adjunct traction tool for ESD and closure of large mucosal defects.
Endoscopic closure devicesSafety data are not available for GI applications of the ... Endoscopic closure of gastro- gastric fistulae by using a tissue apposition system (with videos).
Endoscopic Suturing for Large Submucosal and Full- ...Abstract. This article is a systematic review of relevant literature on endoscopic suturing as a primary closure technique for large ...
New endoscopic closure technique, “internal traction– ...Data from patients in whom this suspended closure technique was used to close full-thickness defects after EFTR were retrospectively reviewed.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security